Beech Biotech SA

Private

LausanneHealthcare & Life Scienceshttps://beech-biotech.com/

Last Round

Pre Seed

Apr 2, 2026

Total Funding Raised

$2.94M

Company Overview

Beech Biotech SA is a biopharmaceutical company developing placenta-impermeable monoclonal antibodies to treat pregnancy complications such as preeclampsia.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

monoclonal antibodypreeclampsiamaternal healthplacenta-impermeablebiopharmaceutical R&Ddrug developmentmother-only therapypregnancy complicationsvirtual biotechtherapeutic platforminvestigational new drugINDwomen's health techfemtechbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Beech Biotech SA Comparables

Compare Beech Biotech SA with similar companies based on industry and business-model similarity.

Beech Biotech SA comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Beech Biotech SA Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Apr 2, 2026
Grant	Jun 27, 2025
Accelerator	Mar 5, 2025

View all Funding Rounds

Beech Biotech SA Investors

Notable investors and investment history

Beech Biotech SA investors
Investor	Rounds
Bill & Melinda Gates Foundation	Grant
Mission BioCapital	Pre Seed
BioInnovation Institute	Accelerator

View all Investors

Beech Biotech SA Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Beech Biotech SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Beech Biotech SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne

Employee Range3

Year Founded2022

Last FundingApr 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.